[go: up one dir, main page]

DK3246325T3 - Krystaller af en 2-acylaminothiazol-forbindelse - Google Patents

Krystaller af en 2-acylaminothiazol-forbindelse Download PDF

Info

Publication number
DK3246325T3
DK3246325T3 DK17176670.2T DK17176670T DK3246325T3 DK 3246325 T3 DK3246325 T3 DK 3246325T3 DK 17176670 T DK17176670 T DK 17176670T DK 3246325 T3 DK3246325 T3 DK 3246325T3
Authority
DK
Denmark
Prior art keywords
acylaminothiazol
crystals
compound
acylaminothiazol compound
Prior art date
Application number
DK17176670.2T
Other languages
English (en)
Inventor
Keizo Sugasawa
Akio Miyafuji
Kenichi Suzuki
Yuji Awamura
Original Assignee
Astellas Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astellas Pharma Inc filed Critical Astellas Pharma Inc
Application granted granted Critical
Publication of DK3246325T3 publication Critical patent/DK3246325T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
DK17176670.2T 2011-08-03 2012-08-01 Krystaller af en 2-acylaminothiazol-forbindelse DK3246325T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2011169730A JP2014144916A (ja) 2011-08-03 2011-08-03 2−アシルアミノチアゾール化合物の結晶
EP12759833.2A EP2739621B1 (en) 2011-08-03 2012-08-01 2-acylaminothiazole compound crystals

Publications (1)

Publication Number Publication Date
DK3246325T3 true DK3246325T3 (da) 2020-04-20

Family

ID=46875935

Family Applications (2)

Application Number Title Priority Date Filing Date
DK17176670.2T DK3246325T3 (da) 2011-08-03 2012-08-01 Krystaller af en 2-acylaminothiazol-forbindelse
DK12759833.2T DK2739621T3 (da) 2011-08-03 2012-08-01 Krystaller med 2-acylaminothiazolforbindelse

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK12759833.2T DK2739621T3 (da) 2011-08-03 2012-08-01 Krystaller med 2-acylaminothiazolforbindelse

Country Status (16)

Country Link
EP (2) EP3246325B1 (da)
JP (1) JP2014144916A (da)
CY (2) CY1120647T1 (da)
DK (2) DK3246325T3 (da)
ES (2) ES2636749T3 (da)
HK (1) HK1246793A1 (da)
HR (2) HRP20171214T1 (da)
HU (1) HUE034270T2 (da)
LT (3) LT2739621T (da)
NO (1) NO2020032I1 (da)
PL (2) PL3246325T3 (da)
PT (2) PT3246325T (da)
RS (1) RS60358B1 (da)
SI (2) SI2739621T1 (da)
SM (1) SMT202000173T1 (da)
WO (1) WO2013018362A1 (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2764866A1 (en) 2013-02-07 2014-08-13 IP Gesellschaft für Management mbH Inhibitors of nedd8-activating enzyme
CN106749226B (zh) * 2017-03-15 2019-12-20 广东赛拓医药科技有限公司 一种avatrombopag马来酸盐晶型C的制备方法
WO2020044364A1 (en) 2018-08-27 2020-03-05 Mylan Laboratories Limited Polymorphic forms of avatrombopag maleate
CN112022825B (zh) * 2020-08-24 2024-03-22 瑞阳制药股份有限公司 马来酸阿伐曲泊帕片剂及其制备方法
CN112409350B (zh) * 2020-11-27 2023-12-19 上海迪赛诺生物医药有限公司 一种马来酸阿伐曲泊帕晶型c的制备方法
CN113185510B (zh) * 2021-04-12 2022-05-13 南京海纳医药科技股份有限公司 一种阿伐曲泊帕杂质的制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2610611T3 (es) 2002-01-18 2017-04-28 Astellas Pharma Inc. Derivado de 2-acilaminotiazol o sal del mismo
AU2003268687A1 (en) 2002-09-30 2004-04-19 Yamanouchi Pharmaceutical Co., Ltd. Novel salt of 2-acylaminothiazole derivative

Also Published As

Publication number Publication date
ES2784384T3 (es) 2020-09-24
EP2739621B1 (en) 2017-06-21
RS60358B1 (sr) 2020-07-31
EP3246325B1 (en) 2020-03-25
HRP20171214T1 (hr) 2017-10-20
JP2014144916A (ja) 2014-08-14
NO2020032I1 (no) 2020-09-14
DK2739621T3 (da) 2017-09-04
SI2739621T1 (sl) 2017-10-30
PL2739621T3 (pl) 2017-12-29
HK1246793A1 (zh) 2018-09-14
CY1122974T1 (el) 2021-10-29
HUE034270T2 (en) 2018-02-28
CY1120647T1 (el) 2019-12-11
ES2636749T3 (es) 2017-10-09
LT2739621T (lt) 2017-09-25
LT3246325T (lt) 2020-05-11
PT3246325T (pt) 2020-04-21
SI3246325T1 (sl) 2020-07-31
LTPA2020526I1 (lt) 2020-09-25
PL3246325T3 (pl) 2020-07-27
WO2013018362A1 (en) 2013-02-07
EP3246325A1 (en) 2017-11-22
EP2739621A1 (en) 2014-06-11
PT2739621T (pt) 2017-08-16
HRP20200546T1 (hr) 2020-08-07
SMT202000173T1 (it) 2020-05-08

Similar Documents

Publication Publication Date Title
DK2863918T3 (da) Saltkrystaller af en pde1- inhibitor
DK3235812T3 (da) Deutererede derivater af ivacaftor
LT2751083T (lt) Kvinolono junginys
EP2738170A4 (en) HETEROCYCLIC CONNECTION
CO6900145A2 (es) Compuesto de ciclopropanoamina
SMT201600227B (it) Composto di guanidina
DK2693881T3 (da) Substituerede n-phenylpyrimidin-2-amin-analoger som inhibitorer af axl-kinase
DK2896405T3 (da) Fremstilling af gadobutrol med høj renhed
DK3470397T3 (da) Krystallinske former af en prolylhydroxylaseinhibitor
UY4115Q (es) Reloj
BR112014012016A2 (pt) compostos
EP2759533A4 (en) CONDENSED HETEROCYCLIC COMPOUND
CO6910197A2 (es) Compuestos novedosos
EP2763697C0 (en) ADJUVANT COMPOUND
LTPA2020526I1 (lt) 2-Acilaminotiazolo junginio kristalai
DK2733803T4 (da) Sektion af kabelbakke
DK2706977T3 (da) Dispergeringsmidler med biobaserede forbindelser
EP2669278A4 (en) CHROME LINK
BR112013028029A2 (pt) composto
DE112012002395A5 (de) Lagerung einer Nockenwelle
DK2698366T3 (da) Fremgangsmåde til fremstilling af mandelonitrilforbindelse
DK2731572T3 (da) Forbedringer af indgivelsesanordninger
IL231235A0 (en) Benzothiazolone compound
BR112014015607A2 (pt) composto
BR112013032866A2 (pt) composto